Physician profile
Troy E Pascoe
NPI 1619979838
$1,717.02
in general payments reported to CMS, 2019-2025
41 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $29.61 · 2021: $86.31 · 2022: $498 · 2023: $475 · 2024: $314 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $890.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $272.77 | 2022-2023 | Gvoke Hypopen |
| Smith+Nephew, INC. | $237.91 | 2019-2025 | Renasys Touch, Pico 7, Collagenase Santyl |
| Merck Sharp & Dohme LLC | $84.02 | 2023-2024 | Gardasil 9, Capvaxive, Gardasil |
| Novo Nordisk INC | $83.44 | 2019-2024 | Wegovy |
| Bioventus LLC | $79.29 | 2022-2023 | Sonicone Clinic |
| Kerecis Limited | $70.42 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Astrazeneca Pharmaceuticals LP | $65.02 | 2022-2024 | Farxiga |
| Abbvie INC. | $61.51 | 2022-2023 | |
| Pfizer INC. | $56.84 | 2023 | |
| Convatec INC. | $50.47 | 2019-2024 | |
| Glaxosmithkline, LLC. | $46.84 | 2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Janssen Pharmaceuticals, INC | $41.93 | 2020-2022 | |
| Lilly USA, LLC | $41.44 | 2023 | Mounjaro, Jardiance |
| Tactile Systems Technology INC | $27.89 | 2025 | Nimbl, Flexitouch Plus |
| Cashflow Solutions, LLC | $26.82 | 2022-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Pascoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.